- Filed
- May 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 49.13M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 49.24M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 48.01M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $78.4M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $60.01M |
| Capex | Q1 2026 · Mar 31, 2026 | $70.85M |
| Capex | Q1 2026 · Mar 31, 2025 | $40.34M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $250.25M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $256.39M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $304.18M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $157.24M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.06B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.1B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $637.35M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.68B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.53B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $3.07B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $2.95B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $486.96M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $369.37M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $771.46M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $662.7M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.33B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.18B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.45B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.19B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.92 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $2.81 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $3.94 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $2.82 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $103.35M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $92.24M |
| Net Income | Q1 2026 · Mar 31, 2026 | $193.23M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $135.05M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $241.15M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $168.76M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $445.07M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $353.23M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $359.12M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $284.32M |
| Revenue | Q1 2026 · Mar 31, 2026 | $804.19M |
| Revenue | Q1 2026 · Mar 31, 2025 | $637.55M |